![Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar | Nature Communications Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35653-z/MediaObjects/41467_2022_35653_Fig1_HTML.png)
Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar | Nature Communications
![The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data - eBioMedicine The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data - eBioMedicine](https://www.thelancet.com/cms/asset/c5242a94-b2bf-49c8-8b7a-d959f80a15be/gr1.jpg)
The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data - eBioMedicine
![Moderna on Twitter: "Today, we shared positive pre-clinical data demonstrating our ability to combine 6 mRNAs against 3 different respiratory viruses in 1 vaccine: COVID-19 booster + Flu booster + RSV booster. # Moderna on Twitter: "Today, we shared positive pre-clinical data demonstrating our ability to combine 6 mRNAs against 3 different respiratory viruses in 1 vaccine: COVID-19 booster + Flu booster + RSV booster. #](https://pbs.twimg.com/media/E-2be3DXIAIFcoo.jpg)